The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.

2 The Ministry of Food and Drug Safety (MFDS) has reported an increasing trend of trials for severe and rare incurable diseases. 2 Anti-cancer clinical trials account for 36.4% of all clinical trials, and have been the most common indication of clinical trial for 3 consecutive years. 2 The conduct of clinical trials consists of a series of processes and multiple parties are involved in the overall trial process. 3 Accordingly, face to face contact, meetings and travel to designated places are required ( Fig. 1 ).

also in 63,971 other papers